Sansure Biotech (688289.SS) Stock Price
Sansure Biotech Price
Over the last 8 years Sansure Biotech grew revenue by 28.3% annually, reaching 1.65 B CNY. Earnings per share have grown at 62.0% per year over the last 7 years. For Sansure Biotech, the net margin of 12.0% is down versus 49.7% a few years ago. At today's price the dividend yield works out to roughly 3.41%. The payout ratio is around 160% of earnings. The dividend has grown at 1.2% per year over the past 5 years. The consensus 12-month price target for Sansure Biotech is 26.42 CNY, about 67.6% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Sansure Biotech stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Sansure Biotech business model & stock analysis
Frequently asked questions about Sansure Biotech
Analysts currently set an average price target of 26.42 CNY for the Sansure Biotech stock (median: 26.42 CNY), implying +67.6 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Sansure Biotech stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sansure Biotech to generate revenue of 1.73 B CNY and earnings per share of 0.40 CNY.
Converted at the current exchange rate, the Sansure Biotech share trades at 2.09 EUR (15.76 CNY).
The Sansure Biotech share (688289.SS) is listed on 1 stock exchanges, including: Shanghai (688289.SS).
The expected revenue of Sansure Biotech is 1.73 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Sansure Biotech is 237.48 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sansure Biotech is currently 39.28. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sansure Biotech stock.
The price-to-sales ratio (P/S) of Sansure Biotech is currently 5.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sansure Biotech stock.
The Eulerpool Quality Score for Sansure Biotech is 2/10.
The ISIN of Sansure Biotech is CNE1000043J1. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sansure Biotech is 688289.SS. The ticker symbol is used to trade Sansure Biotech shares on the stock exchange.
Sansure Biotech stock
Sansure Biotech Peer Group
Sansure Biotech Ticker
Sansure Biotech FIGI
All fundamentals and in-depth analysis of Sansure Biotech
Our stock analysis for Sansure Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sansure Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.